Abstract
In patients with COPD, targeting IL-33 might be auspicious in former smokers. However, disease severity should also be considered. In patients with severe asthma, targeting IL-33 might be a potential treatment option, irrespective of T2-status. https://bit.ly/3SFspww
MeSH terms
-
Adult
-
Aged
-
Asthma* / metabolism
-
Female
-
Humans
-
Inflammation*
-
Interleukin-33* / metabolism
-
Male
-
Middle Aged
-
Pulmonary Disease, Chronic Obstructive* / metabolism
-
Smoking*
-
Sputum* / metabolism
Substances
-
Interleukin-33
-
IL33 protein, human